找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Methods of Cancer Diagnosis, Therapy, and Prognosis; Liver Cancer M. A. Hayat Book 20091st edition Springer Science+Business Media B.V. 200

[復(fù)制鏈接]
查看: 40602|回復(fù): 35
樓主
發(fā)表于 2025-3-21 18:03:51 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Methods of Cancer Diagnosis, Therapy, and Prognosis
副標(biāo)題Liver Cancer
編輯M. A. Hayat
視頻videohttp://file.papertrans.cn/588/587399/587399.mp4
概述The only book that discusses cancer diagnosis, therapy, and prognosis together in one volume.Discusses the molecular processes that lead to the development and proliferation of cancer cells.Includes r
叢書名稱Methods of Cancer Diagnosis, Therapy and Prognosis
圖書封面Titlebook: Methods of Cancer Diagnosis, Therapy, and Prognosis; Liver Cancer M. A. Hayat Book 20091st edition Springer Science+Business Media B.V. 200
描述This volume presents a detailed survey of imaging, multidetector-row computed t- various methodologies related to diagno- ography, helical computed tomography, sis, therapy, and prognosis of liver cancer, ultrasonography, and power Doppler ult- including colorectal liver metastases and sound, for the prognosis and assessment of biliary tract carcinomas, while the already liver cancer treatment (including HCC) and published Volumes 1, 2, 3, and 4 detail liver metastases from colorectal cancer are similar aspects of breast, lung, prostate, discussed in detail, as is the use of radiof- gastrointestinal, and colorectal cancer, quency ablation in hepatic tumors. respectively. Approximately 50% of colorectal cancer Surgical resection is the standard therapy (CRC) patients develop liver metastases for resectable liver disease, resulting in during the course of their disease, and 5-year overall survival rates of 20–40%. more than 50% of patients who die of CRC One the other hand, the median overall have liver metastases at autopsy. Regional survival of patients with unresectable liver lymph node (RLN) involvement in patients metastases does not exceed 18–20 months, with colorectal liver me
出版日期Book 20091st edition
關(guān)鍵詞Liver; Staging; Tumor; carcinoma; computed tomography (CT); diagnosis; imaging; imaging techniques; liver tu
版次1
doihttps://doi.org/10.1007/978-1-4020-9804-8
isbn_softcover978-90-481-8204-6
isbn_ebook978-1-4020-9804-8
copyrightSpringer Science+Business Media B.V. 2009
The information of publication is updating

書目名稱Methods of Cancer Diagnosis, Therapy, and Prognosis影響因子(影響力)




書目名稱Methods of Cancer Diagnosis, Therapy, and Prognosis影響因子(影響力)學(xué)科排名




書目名稱Methods of Cancer Diagnosis, Therapy, and Prognosis網(wǎng)絡(luò)公開度




書目名稱Methods of Cancer Diagnosis, Therapy, and Prognosis網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Methods of Cancer Diagnosis, Therapy, and Prognosis被引頻次




書目名稱Methods of Cancer Diagnosis, Therapy, and Prognosis被引頻次學(xué)科排名




書目名稱Methods of Cancer Diagnosis, Therapy, and Prognosis年度引用




書目名稱Methods of Cancer Diagnosis, Therapy, and Prognosis年度引用學(xué)科排名




書目名稱Methods of Cancer Diagnosis, Therapy, and Prognosis讀者反饋




書目名稱Methods of Cancer Diagnosis, Therapy, and Prognosis讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:39:26 | 只看該作者
median overall have liver metastases at autopsy. Regional survival of patients with unresectable liver lymph node (RLN) involvement in patients metastases does not exceed 18–20 months, with colorectal liver me978-90-481-8204-6978-1-4020-9804-8
板凳
發(fā)表于 2025-3-22 04:28:52 | 只看該作者
Book 20091st editionsurvival rates of 20–40%. more than 50% of patients who die of CRC One the other hand, the median overall have liver metastases at autopsy. Regional survival of patients with unresectable liver lymph node (RLN) involvement in patients metastases does not exceed 18–20 months, with colorectal liver me
地板
發(fā)表于 2025-3-22 06:43:36 | 只看該作者
Methods of Cancer Diagnosis, Therapy, and PrognosisLiver Cancer
5#
發(fā)表于 2025-3-22 09:04:48 | 只看該作者
Methods of Cancer Diagnosis, Therapy, and Prognosis978-1-4020-9804-8
6#
發(fā)表于 2025-3-22 15:36:27 | 只看該作者
7#
發(fā)表于 2025-3-22 19:15:51 | 只看該作者
8#
發(fā)表于 2025-3-22 22:45:43 | 只看該作者
Methods of Cancer Diagnosis, Therapy and Prognosishttp://image.papertrans.cn/l/image/587399.jpg
9#
發(fā)表于 2025-3-23 03:04:01 | 只看該作者
10#
發(fā)表于 2025-3-23 06:39:17 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 05:31
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
江孜县| 三亚市| 钟山县| 日照市| 昭通市| 孝义市| 苏州市| 海阳市| 如皋市| 南郑县| 梧州市| 霞浦县| 定边县| 惠来县| 普兰店市| 民乐县| 子长县| 永州市| 河间市| 咸宁市| 定西市| 临朐县| 清水县| 建平县| 黎川县| 彰武县| 昂仁县| 双江| 稷山县| 东山县| 余庆县| 积石山| 讷河市| 文昌市| 涿鹿县| 古交市| 巴彦县| 松阳县| 潜江市| 武汉市| 南充市|